UVAR PHOTOPHORESIS SYSTEM
FDA premarket approval P860003/S030 · decided 1999-09-07
Approval details
- PMA number
- P860003
- Supplement
- S030
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- UVAR PHOTOPHORESIS SYSTEM
- Generic name
- System, photopheresis, extracorporeal
- Applicant
- Therakos Development Limited
- Date received
- 1998-04-29
- Decision date
- 1999-09-07
- Days to decision
- 496 days
- Decision code
- APPR
- Product code
- LNR
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Dublin
- Statement
- Approval for a labeling change to reflect the use of UVADEX(R), the sterile liquid formulation of 8-methoxypsoralen (8-mop).
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.